Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma
10.1371/journal.pone.0146003
Saved in:
| Main Authors: | , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | English |
| Published: |
PUBLIC LIBRARY SCIENCE
2022
|
| Subjects: | |
| Online Access: | https://scholarbank.nus.edu.sg/handle/10635/226813 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| Language: | English |
| id |
sg-nus-scholar.10635-226813 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-2268132023-11-01T08:43:27Z Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma Zafari, Zafar Sadatsafavi, Mohsen Marra, Carlo A Chen, Wenjia FitzGerald, J Mark SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH Science & Technology Multidisciplinary Sciences Science & Technology - Other Topics ANTI-IGE ANTIBODY ADD-ON THERAPY SEVERE PERSISTENT UNCONTROLLED ASTHMA HEALTH ADULTS SAFETY EFFICACY CORTICOSTEROIDS EXACERBATIONS 10.1371/journal.pone.0146003 PLOS ONE 11 1 2022-06-09T04:03:34Z 2022-06-09T04:03:34Z 2016-01-11 2022-06-09T02:33:21Z Article Zafari, Zafar, Sadatsafavi, Mohsen, Marra, Carlo A, Chen, Wenjia, FitzGerald, J Mark (2016-01-11). Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma. PLOS ONE 11 (1). ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0146003 19326203 https://scholarbank.nus.edu.sg/handle/10635/226813 en PUBLIC LIBRARY SCIENCE Elements |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| language |
English |
| topic |
Science & Technology Multidisciplinary Sciences Science & Technology - Other Topics ANTI-IGE ANTIBODY ADD-ON THERAPY SEVERE PERSISTENT UNCONTROLLED ASTHMA HEALTH ADULTS SAFETY EFFICACY CORTICOSTEROIDS EXACERBATIONS |
| spellingShingle |
Science & Technology Multidisciplinary Sciences Science & Technology - Other Topics ANTI-IGE ANTIBODY ADD-ON THERAPY SEVERE PERSISTENT UNCONTROLLED ASTHMA HEALTH ADULTS SAFETY EFFICACY CORTICOSTEROIDS EXACERBATIONS Zafari, Zafar Sadatsafavi, Mohsen Marra, Carlo A Chen, Wenjia FitzGerald, J Mark Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma |
| description |
10.1371/journal.pone.0146003 |
| author2 |
SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH |
| author_facet |
SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH Zafari, Zafar Sadatsafavi, Mohsen Marra, Carlo A Chen, Wenjia FitzGerald, J Mark |
| format |
Article |
| author |
Zafari, Zafar Sadatsafavi, Mohsen Marra, Carlo A Chen, Wenjia FitzGerald, J Mark |
| author_sort |
Zafari, Zafar |
| title |
Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma |
| title_short |
Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma |
| title_full |
Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma |
| title_fullStr |
Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma |
| title_full_unstemmed |
Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma |
| title_sort |
cost-effectiveness of bronchial thermoplasty, omalizumab, and standard therapy for moderate-to-severe allergic asthma |
| publisher |
PUBLIC LIBRARY SCIENCE |
| publishDate |
2022 |
| url |
https://scholarbank.nus.edu.sg/handle/10635/226813 |
| _version_ |
1781793083092893696 |